Status:
COMPLETED
Beta-Cell Function After Near-Normalisation of Blood Glucose
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The incretin effect is attenuated in patients with type 2 diabetes mellitus partly due to impaired potentiation of beta-cell responsiveness to glucose by glucose dependent insulinotropic polypeptide a...
Eligibility Criteria
Inclusion
- Age 18-70 years
- Type 2 diabetes diagnosed after 30 years of age
- BMI \> 25
Exclusion
- Severe complications to diabetes
- Abnormal liver and kidney function
- Haemoglobin below the lower limit
- Macroalbuminuria
- Systemic disease
- Pregnancy
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00612950
Start Date
October 1 2006
End Date
May 1 2007
Last Update
February 12 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Endocrinology, Hvidovre Hospital
Copenhagen, Denmark